0102030405
CAS No 1859053-21-6 RUCAPARIB CAMSYLATE Pharmaceutical Intermediates
02
overview
Rucaparib Camsylate is an advanced pharmaceutical compound that has attracted much attention for its role in cancer treatment. This drug is specifically designed to inhibit the PARP enzyme, which plays a vital role in the DNA repair mechanism of cancer cells.
By targeting this pathway, Rucaparib Camsylate may enhance the effectiveness of chemotherapy and help improve patient outcomes in advanced ovarian cancer treatment.
As a product of our integrated manufacturing and trading facility, Rucaparib Camsylate embodies our commitment to quality, innovation and customer satisfaction.
By targeting this pathway, Rucaparib Camsylate may enhance the effectiveness of chemotherapy and help improve patient outcomes in advanced ovarian cancer treatment.
As a product of our integrated manufacturing and trading facility, Rucaparib Camsylate embodies our commitment to quality, innovation and customer satisfaction.
02
Physical and chemical properties
- Molecular weight: 555.67 g/mol
- Solubility: It is soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, but has limited solubility in water. This property is beneficial for certain drug formulations.
- Stability: The compound exhibits good stability under standard storage conditions, ensuring a longer shelf life and maintaining its therapeutic effects.
These properties not only enhance the performance of Rucaparib Camsylate in pharmaceutical formulations but also enhance its versatility for various applications in cancer therapy.
- Solubility: It is soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, but has limited solubility in water. This property is beneficial for certain drug formulations.
- Stability: The compound exhibits good stability under standard storage conditions, ensuring a longer shelf life and maintaining its therapeutic effects.
These properties not only enhance the performance of Rucaparib Camsylate in pharmaceutical formulations but also enhance its versatility for various applications in cancer therapy.
1. Targeted cancer therapy: Rucaparib Camsylate specifically targets BRCA mutated cancer cells, providing a personalized treatment approach and enhancing treatment outcomes.
2. Enhanced Efficacy: By inhibiting the PARP enzyme, Rucaparib Camsylate increases the sensitivity of cancer cells to DNA damaging agents, making it a powerful adjunct to chemotherapy.
3. Convenient Dosing Regimen: Rucaparib Camsylate is typically administered orally, providing a convenient dosing schedule that can improve patient compliance and overall treatment experience.
4. Established Safety: Rucaparib Camsylate has a well-documented safety profile and is a trusted ingredient in cancer treatment regimens. Its use is supported by numerous research studies and clinical studies, ensuring that safety and efficacy standards are met.
5. Cost Effective: As a product of our integrated facility, Rucaparib Camsylate is available at a very competitive price without compromising on quality. This cost effectiveness makes it an ideal choice for pharmaceutical companies and healthcare providers.
6. Sustainability: We are committed to sustainable manufacturing practices, ensuring that Rucaparib Camsylate is produced with minimal impact on the environment. We prioritize environmentally friendly processes and materials to meet the growing demand for sustainable pharmaceutical solutions.
2. Enhanced Efficacy: By inhibiting the PARP enzyme, Rucaparib Camsylate increases the sensitivity of cancer cells to DNA damaging agents, making it a powerful adjunct to chemotherapy.
3. Convenient Dosing Regimen: Rucaparib Camsylate is typically administered orally, providing a convenient dosing schedule that can improve patient compliance and overall treatment experience.
4. Established Safety: Rucaparib Camsylate has a well-documented safety profile and is a trusted ingredient in cancer treatment regimens. Its use is supported by numerous research studies and clinical studies, ensuring that safety and efficacy standards are met.
5. Cost Effective: As a product of our integrated facility, Rucaparib Camsylate is available at a very competitive price without compromising on quality. This cost effectiveness makes it an ideal choice for pharmaceutical companies and healthcare providers.
6. Sustainability: We are committed to sustainable manufacturing practices, ensuring that Rucaparib Camsylate is produced with minimal impact on the environment. We prioritize environmentally friendly processes and materials to meet the growing demand for sustainable pharmaceutical solutions.
In summary, Rucaparib Camsylate has become the first choice for the treatment of advanced ovarian cancer with its innovative mechanism of action, enhanced efficacy and strong safety.
With Rucaparib Camsylate, you can be confident that you are choosing a reliable and effective solution for your pharmaceutical needs.
As a factory integrating production and trading, we are committed to providing customers with high-quality products that meet the highest industry standards.
Work with us today to experience the benefits of Rucaparib Camsylate and enhance your pharmaceutical supply in cance
With Rucaparib Camsylate, you can be confident that you are choosing a reliable and effective solution for your pharmaceutical needs.
As a factory integrating production and trading, we are committed to providing customers with high-quality products that meet the highest industry standards.
Work with us today to experience the benefits of Rucaparib Camsylate and enhance your pharmaceutical supply in cance